查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1561552

2024-2032 年按產品類型、應用、配銷通路和地區分類的鴉片類藥物市場報告

Opioids Market Report by Product Type, Application, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2023年全球鴉片類藥物IMARC Group規模達219億美元。慢性疼痛發生率的上升、老年人口的增加、癌症診斷的增加、醫療保健服務的改善、持續的研發（R＆D）努力、消費者意識的提高以及有利的政府法規是推動市場的一些主要因素。

鴉片類藥物市場分析：

  • 主要市場促進因素：鴉片類藥物市場分析確定了重要因素，例如慢性疼痛、老年人口成長以及關節炎和癌症等疾病盛行率的增加。
  • 主要市場趨勢：根據鴉片類藥物市場預測，主要趨勢包括持續轉向開發鴉片類藥物的防濫用製劑（ADF），以最大限度地降低成癮風險。
  • 地理趨勢：由於處方率高、醫療保健系統完善以及人口中慢性疼痛的盛行率，鴉片類藥物市場以北美為主。由於醫療保健支出增加、對疼痛管理方案的認知以及基礎設施擴建，其他地區也正在經歷成長。
  • 競爭格局：鴉片類藥物產業的一些主要市場參與者包括勃林格殷格翰國際有限公司、Hikma Pharmaceuticals PLC、Mallinckrodt plc、輝瑞公司、Purdue Pharma LP、賽諾菲SA、Sun Pharmaceutical Industries Ltd. 和Teva Pharmaceutical Industries Ltd.。
  • 挑戰與機會：鴉片類藥物市場面臨挑戰，例如更嚴格的監管控制和對非鴉片類疼痛管理方案的需求增加。然而，有機會開發和銷售有效且不太可能導致濫用和成癮的新鴉片類製劑。

鴉片類藥物市場趨勢：

慢性疼痛的盛行率不斷增加

全球慢性疼痛發生率不斷上升是鴉片類藥物產業成長的主要驅動力。 2021 年，超過 20.9% 的美國成年人（5,160 萬人）患有慢性疼痛，而 6.9%（1,710 萬人）報告患有高影響慢性疼痛（即嚴重限制日常活動的疼痛）。數百萬人患有慢性疼痛，這通常是由關節炎、背部困難或神經性疾病等疾病引起的，這促進了有效疼痛管理治療的使用。根據美國疾病管制與預防中心 (CDC) 的數據，2019 年至 2021 年，約 5,320 萬美國人 (21.2%) 被醫生診斷出患有關節炎。因此，鴉片類藥物因其治療劇烈疼痛的功效而被醫療保健從業者開出處方。

老年人口不斷增加

鴉片類藥物行業是由不斷成長的老年人口推動的。 2022年，65歲以上人口為7.71億，約佔全球人口的10%。 2022年，印度60歲以上人口為1.49億，約佔總人口的10.5%。此外，預計2023年歐盟（EU）人口將達到4.488億，其中超過五分之一（21.3%）年齡在65歲及以上。老年人更有可能因與年齡相關的疾病（例如退化性關節病和癌症）而忍受慢性疼痛。這增加了對疼痛治療選擇的需求。據估計，在美國 65 歲及以上的成年人中，47% 被診斷出患有關節炎。此外，骨關節炎是第二常見的風濕病，也是最常見的關節疾病，在印度盛行率為 22% 至 39%。近 45% 的 65 歲以上女性有症狀，而 70% 的 65 歲以上女性中有放射學證據。

全球癌症發生率上升

癌症診斷率的不斷上升，特別是在新興國家，正在刺激對鴉片類藥物的需求。國際癌症研究機構 (IARC) 估計，2022 年將出現 2,000 萬新癌症病例和 970 萬人死亡。此外，大約五分之一的人在一生中罹患癌症，每九分之一的男性和每十二分之一的女性死於這種疾病。癌症患者經常經歷嚴重的疼痛，鴉片類藥物是癌症疼痛治療的關鍵組成部分。隨著國際上癌症發生率的增加，對有效疼痛管理的需求也在增加，推動了鴉片類藥物產業的擴張。

鴉片類藥物市場細分：

IMARC Group提供了每個細分市場的主要趨勢的分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據產品類型、應用和配銷通路對市場進行了分類。

按產品類型分類：

  • 可待因
  • 芬太尼
  • 美沙酮
  • 羥考酮
  • 嗎啡
  • 氫可酮

羥考酮佔大部分市場佔有率

該報告根據產品類型對市場進行了詳細的細分和分析。這包括可待因、芬太尼、美沙酮、羥考酮、嗎啡和氫可酮。根據該報告，羥考酮代表了最大的部分。

根據鴉片類藥物市場統計數據，羥考酮因其強大的止痛特性而成為主導產品類型，這使得它在治療嚴重疼痛（包括術後疼痛和癌症相關疼痛）方面非常有效。當其他疼痛治療方法證明不足時，醫生經常會開出羥考酮。此外，製藥業在羥考酮緩釋製劑的開發上投入了大量資金，以更少的給藥間隔提供長期的疼痛緩解。此外，羥考酮的多功能性允許多種給藥途徑，包括口服片劑、膠囊和靜脈製劑，滿足不同患者的需求，這反過來又推動了其採用。

按應用分類：

  • 疼痛管理
  • 咳嗽治療
  • 腹瀉治療
  • 其他

疼痛管理佔產業最大佔有率

報告還提供了基於應用程式的詳細市場細分和分析。這包括疼痛管理、咳嗽治療、腹瀉治療等。報告稱，疼痛管理佔最大的市場佔有率。

根據鴉片類藥物市場趨勢，疼痛管理佔據最大的市場佔有率。鴉片類藥物在醫療保健領域的基本作用以及人們對有效解決疼痛重要性的日益認知正在推動其在疼痛管理應用中的採用。疼痛是一種普遍而複雜的醫療問題，影響著全世界數百萬人，鴉片類藥物被認為是治療中度至重度疼痛的關鍵組成部分，特別是在急性和慢性疼痛、術後恢復和癌症相關疼痛中。由於老年人口的迅速成長和癌症診斷發生率的上升，與疼痛相關的疾病普遍存在，從而產生了對有效止痛方法的持續需求，從而擴大了鴉片類藥物的市場佔有率。

按配銷通路分類：

  • 醫院藥房
  • 零售藥局
  • 藥局
  • 網路商店
  • 其他

該報告根據配銷通路對市場進行了詳細的細分和分析。這包括醫院藥局、零售藥局、藥局、網路商店等。

根據鴉片類藥物市場概況，醫院藥房是一個重要的配銷通路，因為這些場所是患者第一次接觸鴉片類藥物處方，尤其是在手術後或用於急性疼痛管理時。它們確保受控的分配和使用，在醫療監督下提供鴉片類藥物的處方和管理之間的直接聯繫。

根據鴉片類藥物市場分析，零售藥局是患者最容易取得鴉片類藥物處方以治療慢性疼痛的地方。它們滿足醫院外患者的持續需求，促進醫療保健提供者提供護理的連續性。零售藥局提供廣泛的可用性和便利性，並在某些地區提供諮詢服務以確保安全使用，從而增加了鴉片類藥物市場的收入。

根據鴉片類藥物市場報告，藥局提供更廣泛的購物體驗，特別注重健康。它們為患者提供了獲取藥物和其他醫療保健產品的便利選擇。藥局在鴉片類藥物行業中的作用強調了獲得必要藥物與限制獲得處方藥以防止濫用的責任之間的平衡。

線上藥局代表了鴉片類藥物市場中不斷成長的部分，為患者提供便利性並降低藥物價格。此外，數位健康技術的快速進步和消費者行為的變化有利於向線上購物的轉變。除此之外，線上藥局增加了服務不足或農村地區獲得疼痛管理解決方案的機會。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美市場領先，佔據最大的鴉片類藥物市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是鴉片類藥物最大的區域市場。

根據鴉片類藥物市場前景，由於多種因素，北美地區佔據了市場佔有率，包括背痛和骨關節炎等慢性疼痛疾病的高患病率、人口老齡化以及鴉片類藥物在疼痛管理中的廣泛使用。除此之外，醫療基礎設施的改善和對疼痛管理選擇的認知提高導致鴉片類藥物處方率上升，對鴉片類藥物市場需求產生了積極影響。此外，專門的成癮治療中心和藥房已成為分銷管道，滿足了對這些藥物的需求。此外，在更嚴格的指南和處方監控計劃的影響下，不斷發展的法規和處方實踐正在影響鴉片類藥物市場的成長。

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

  • 根據最近分析鴉片類藥物市場近期發展的研究發現，領先的製藥公司正在大力投資研發（R＆D）以開發創新的鴉片類藥物製劑。這些努力的重點是創造具有改進的安全性、減少濫用可能性並增強疼痛管理功效的鴉片類藥物。目標是為醫療保健專業人員提供更有效、更安全的治療選擇。此外，鴉片類藥物市場公司正在密切監控和遵守與鴉片類藥物處方、分銷和使用相關的不斷變化的法規和指南。他們正在努力確保其產品符合最高的安全和品質標準，同時遵守嚴格的監管要求。所有這些努力正在塑造鴉片類藥物市場的近期價格和機會。

鴉片類藥物市場新聞：

  • 2021年6月，美國食品藥物管理局（FDA）受理普渡製藥公司提交的鹽酸納美芬注射新藥申請（NDA）並授予優先審查資格。該注射劑是一種鴉片拮抗劑，旨在逆轉鴉片類藥物過量。
  • 2024 年 2 月，Hikma Pharmaceuticals PLC 及其全資子公司 Hikma Pharmaceuticals USA Inc. 宣布已原則上達成協議，以解決美國各州、其分支機構和部落國家對該公司提起的幾起鴉片類藥物相關案件。這些案件涉及處方鴉片類藥物的製造和銷售。 Hikma 同意支付最多 1.15 億美元的現金和 3500 萬美元的 Hikma 納洛酮捐贈，納洛酮是一種鴉片類拮抗劑，用於逆轉鴉片類藥物過量的影響。

本報告回答的關鍵問題：

  • 迄今為止，全球鴉片類藥物市場表現如何，未來幾年將如何表現？
  • 全球鴉片類藥物市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球鴉片類藥物市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的鴉片類藥物市場？
  • 依產品類型分類的市場是怎麼樣的？
  • 鴉片類藥物市場中最具吸引力的產品類型是什麼？
  • 基於應用的市場區隔是什麼？
  • 鴉片類藥物市場中最具吸引力的應用是什麼？
  • 基於配銷通路的市場區隔是什麼？
  • 鴉片類藥物市場中最具吸引力的配銷通路是什麼？
  • 市場競爭結構如何？
  • 全球鴉片類藥物市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

  • 迄今為止，全球鴉片類藥物市場表現如何，未來幾年將如何表現？
  • 全球鴉片類藥物市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球鴉片類藥物市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的鴉片類藥物市場？
  • 依產品類型分類的市場是怎麼樣的？
  • 鴉片類藥物市場上最具吸引力的產品類型是什麼？
  • 基於應用的市場區隔是什麼？
  • 鴉片類藥物市場中最具吸引力的應用是什麼？
  • 基於配銷通路的市場區隔是什麼？
  • 鴉片類藥物市場中最具吸引力的配銷通路是什麼？
  • 市場競爭結構如何？
  • 全球鴉片類藥物市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球鴉片類藥物市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品類型

  • 可待因
    • 市場趨勢
    • 市場預測
  • 芬太尼
    • 市場趨勢
    • 市場預測
  • 美沙酮
    • 市場趨勢
    • 市場預測
  • 羥考酮
    • 市場趨勢
    • 市場預測
  • 嗎啡
    • 市場趨勢
    • 市場預測
  • 氫可酮
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按應用

  • 疼痛管理
    • 市場趨勢
    • 市場預測
  • 咳嗽治療
    • 市場趨勢
    • 市場預測
  • 腹瀉治療
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場趨勢
    • 市場預測
  • 零售藥局
    • 市場趨勢
    • 市場預測
  • 藥局
    • 市場趨勢
    • 市場預測
  • 網路商店
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Boehringer Ingelheim International GmbH
    • Hikma Pharmaceuticals PLC
    • Mallinckrodt plc
    • Pfizer Inc.
    • Purdue Pharma LP
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112024A4559

The global opioids market size reached US$ 21.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 28.3 Billion by 2032, exhibiting a growth rate (CAGR) of 2.8% during 2024-2032. The rising incidence of chronic pain conditions, increasing elderly population, increase in cancer diagnoses, improved access to healthcare services, ongoing research and development (R&D) efforts, escalating consumer awareness, and favorable government regulations are some of the major factors propelling the market.

Opioids Market Analysis:

  • Major Market Drivers: The opioid market analysis identifies important factors, such as chronic pain, growing elderly population, and increasing prevalence of diseases including arthritis and cancer.
  • Key Market Trends: Based on the opioid market forecast, the major trends include the ongoing shift towards the development of abuse-deterrent formulations (ADF) of opioids to minimize the risk of addiction.
  • Geographical Trends: The opioid market is dominated by North America due to high prescription rates, a well-established healthcare system, and the prevalence of chronic pain conditions among its population. Other regions are also experiencing growth due to increased healthcare expenditure, awareness of pain management options, and infrastructure expansion.
  • Competitive Landscape: Some of the major market players in the opioids industry include Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd., among many others.
  • Challenges and Opportunities: The opioid market faces challenges, such as stricter regulatory controls and increased demand for non-opioid pain management options. However, there is an opportunity to develop and market new opioid formulations that are effective and less likely to lead to abuse and addiction.

Opioids Market Trends:

Increasing prevalence of chronic pain

The increasing incidence of chronic pain throughout the world is a primary driver of opioid industry growth. In 2021, over 20.9% of U.S. adults (51.6 million) suffered chronic pain, while 6.9% (17.1 million) reported high-impact chronic pain (i.e., pain that significantly limits daily activities). Millions of people suffer from chronic pain, which is commonly caused by ailments, such as arthritis, back difficulties, or neuropathic disorders, boosting the use of effective pain management treatments. In 2019-2021, around 53.2 million US individuals (21.2%) had arthritis diagnosed by a doctor, according to the Center for Disease Control and Prevention (CDC). As a result, opioids are prescribed by healthcare practitioners because of their effectiveness in treating severe pain.

Growing geriatric population

The opioids industry is driven by the growing geriatric population. In 2022, there were 771 million persons aged 65 and over, accounting for about 10% of the global population. In 2022, 14.9 crore people in India were recorded to be 60 years or older, accounting for approximately 10.5% of the total population. In addition, the population of the European Union (EU) was predicted to be 448.8 million in 2023, with more than one-fifth (21.3%) of it aged 65 and more. Geriatric individuals are more likely to endure chronic pain due to age-related disorders, such as degenerative joint disease and cancer. This has raised the need for pain treatment choices. It is estimated that among adults aged 65 and older, 47% are diagnosed with arthritis in the USA. Also, osteoarthritis is the second most common rheumatologic problem, and it is the most frequent joint disease with a prevalence of 22% to 39% in India. Nearly, 45% of women over the age of 65 years have symptoms while radiological evidence is found in 70% of those over 65 years.

Rising cancer rates across the globe

The increasing rate of cancer diagnoses, particularly in emerging nations, is fueling the demand for opioids. The International Agency for Research on Cancer (IARC) estimated that 20 million new cancer cases and 9.7 million deaths occurred in 2022. The expected number of persons who survived 5 years after a cancer diagnosis was 53.5 million. Furthermore, around one in every five persons develops cancer during their lifetime, with one in every nine men and one in every twelve women dying from the condition. Cancer patients frequently experience significant pain, and opioids are a key component of cancer pain therapy. As cancer rates increase internationally, so does the demand for effective pain management, driving the opioid industry expansion.

Opioids Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, application, and distribution channel.

Breakup by Product Type:

  • Codeine
  • Fentanyl
  • Methadone
  • Oxycodone
  • Morphine
  • Hydrocodone

Oxycodone accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes codeine, fentanyl, methadone, oxycodone, morphine, and hydrocodone. According to the report, oxycodone represented the largest segment.

According to the opioids market statistics, oxycodone has emerged as a dominant product type owing to its potent pain-relieving properties, which make it highly effective in managing severe pain, including post-operative and cancer-related pain. Physicians often prescribe oxycodone when other pain management options prove insufficient. Moreover, the pharmaceutical industry has invested significantly in the development of extended-release formulations of oxycodone, offering prolonged pain relief with fewer dosing intervals. Additionally, oxycodone's versatility allows for various administration routes, including oral tablets, capsules, and intravenous formulations, catering to diverse patient needs, which, in turn, is propelling its adoption.

Breakup by Application:

  • Pain Management
  • Cough Treatment
  • Diarrhea Treatment
  • Others

Pain management holds the largest share of the industry

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes pain management, cough treatment, diarrhea treatment, and others. According to the report, pain management accounted for the largest market share.

Based on the opioid market trends, pain management accounted for the largest market share. Opioid's fundamental role in the healthcare sector and the increasing recognition of the importance of effectively addressing pain is fueling its adoption in pain management applications. Pain refers to a pervasive and complex medical issue affecting millions of individuals worldwide, and opioids are considered a crucial component in managing moderate to severe pain, especially in acute and chronic pain conditions, post-surgical recovery, and cancer-related pain. The sheer prevalence of pain-related conditions owing to the burgeoning geriatric population and the rising incidence of cancer diagnoses, thereby creating a sustained demand for effective pain relief methods, is bolstering the opioids market share.

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Stores
  • Others

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospital pharmacies, retail pharmacies, drug stores, online stores, and others.

According to the opioids market overview, hospital pharmacies represent a critical distribution channel as these settings are the first encounters of opioid prescriptions for patients, especially after surgeries or for acute pain management. They ensure controlled distribution and use, providing a direct link between the prescription and administration of opioids under medical supervision.

As per the opioids market analysis, retail pharmacies serve as the most accessible point for patients to fill opioid prescriptions for chronic pain management. They cater to the ongoing needs of patients outside the hospital setting, facilitating the continuity of care prescribed by healthcare providers. Retail pharmacies offer widespread availability, convenience, and, in some regions, counseling services to ensure safe use, boosting the opioid market revenue.

According to the opioids market report, drug stores offer a broader shopping experience with a particular focus on health. They provide a convenient option for patients to access their medications along with other healthcare products. The role of drug stores in the opioid industry underscores the balance between accessibility to necessary medications and the responsibility to limit access to prescription drugs to prevent abuse.

Online pharmacies represent a growing segment in the opioid market, offering patients convenience and lower prices for their medications. Moreover, rapid advancements in digital health technologies and changing consumer behaviors are favoring the shift toward online shopping. Along with this, online pharmacies increase access to pain management solutions in underserved or rural areas.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest opioids market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for opioids.

As per the opioids market outlook, The North American region dominated the market share due to several factors, including a high prevalence of chronic pain conditions, such as back pain and osteoarthritis, an aging population, and the widespread use of opioids in pain management. In addition to this, improved healthcare infrastructure and increased awareness of pain management options have led to higher opioid prescription rates, positively impacting the opioid market demand. Moreover, specialized addiction treatment centers and pharmacies have emerged as distribution channels, addressing the demand for these medications. Furthermore, evolving regulations and prescribing practices, influenced by stricter guidelines and prescription monitoring programs, are influencing the opioid market growth.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the opioids industry include Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • According to recent research that analyzes the opioid market's recent developments, it has been found that leading pharmaceutical companies are investing heavily in research and development (R&D) to develop innovative opioid formulations. These efforts focus on creating opioids with improved safety profiles, reduced potential for abuse, and enhanced efficacy in pain management. The goal is to provide healthcare professionals with more effective and safer treatment options. Moreover, opioid market companies are closely monitoring and complying with evolving regulations and guidelines related to opioid prescribing, distribution, and usage. They are working to ensure that their products meet the highest safety and quality standards while adhering to stringent regulatory requirements. All these efforts are shaping the opioids market's recent price and opportunities.

Opioids Market News:

  • In June 2021, the U.S. Food and Drug Administration (FDA) accepted and granted priority review designation to new drug application (NDA) submitted by Purdue Pharma L.P. for nalmefene hydrochloride injection. The injectable is an opioid antagonist that is designed to reverse opioid overdose.
  • In February 2024, Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc., announced that it has reached an agreement in principle to resolve the several opioid related cases brought against the company by U.S. states, their subdivisions, and tribal nations. These cases relate to the manufacture and sales of prescription opioid medications. Hikma agreed to pay up to $115 million in cash and $35 million in donations of Hikma's naloxone, an opioid antagonist that is used to reverse the effects of opioid overdose.

Key Questions Answered in This Report:

  • How has the global opioids market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global opioids market?
  • What is the impact of each driver, restraint, and opportunity on the global opioids market?
  • What are the key regional markets?
  • Which countries represent the most attractive opioids market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the opioids market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the opioids market?
  • What is the breakup of the market based on the distribution channel?
  • Which is the most attractive distribution channel in the opioids market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global opioids market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Opioids Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Codeine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Fentanyl
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Methadone
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Oxycodone
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Morphine
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Hydrocodone
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Pain Management
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cough Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diarrhea Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Drug Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Stores
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boehringer Ingelheim International GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Hikma Pharmaceuticals PLC
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Mallinckrodt plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Pfizer Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Purdue Pharma L.P.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Sanofi S.A.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Sun Pharmaceutical Industries Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Teva Pharmaceutical Industries Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Opioids Market: Major Drivers and Challenges
  • Figure 2: Global: Opioids Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Opioids Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Opioids Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Opioids Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Opioids Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Opioids Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Opioids (Codeine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Opioids (Codeine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Opioids (Fentanyl) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Opioids (Fentanyl) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Opioids (Methadone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Opioids (Methadone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Opioids (Oxycodone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Opioids (Oxycodone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Opioids (Morphine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Opioids (Morphine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Opioids (Hydrocodone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Opioids (Hydrocodone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Opioids (Pain Management) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Opioids (Pain Management) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Opioids (Cough Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Opioids (Cough Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Opioids (Diarrhea Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Opioids (Diarrhea Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Opioids (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Opioids (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Opioids (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Opioids (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Opioids (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Opioids (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Opioids (Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Opioids (Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Opioids (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Opioids (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Opioids (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Opioids (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: North America: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: North America: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: United States: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: United States: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Canada: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Canada: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Asia-Pacific: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Asia-Pacific: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: China: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: China: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Japan: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Japan: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: India: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: India: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: South Korea: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: South Korea: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Australia: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Australia: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Indonesia: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Indonesia: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Europe: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Europe: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Germany: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Germany: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: France: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: France: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: United Kingdom: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: United Kingdom: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Italy: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Italy: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Spain: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Spain: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Russia: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Russia: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Latin America: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Latin America: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Brazil: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Brazil: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Mexico: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Mexico: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Middle East and Africa: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Middle East and Africa: Opioids Market: Breakup by Country (in %), 2023
  • Figure 86: Middle East and Africa: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Global: Opioids Industry: SWOT Analysis
  • Figure 88: Global: Opioids Industry: Value Chain Analysis
  • Figure 89: Global: Opioids Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Opioids Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Opioids Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Opioids Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Opioids Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Opioids Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Opioids Market: Competitive Structure
  • Table 7: Global: Opioids Market: Key Players